by MM360 Staff | Jun 2, 2025 | Uncategorized
Source: CureToday articles Dr. Guru Sonpavde discusses the CheckMate 901 trial evaluating Opdivo plus Yervoy for those with cisplatin-ineligible, metastatic urothelial carcinoma. Read More
by MM360 Staff | Jun 2, 2025 | Myeloma News
Source: Pharmacy Times articles Gaps in curricula emphasize a need for enhanced interprofessional training to improve patient care. Read More
by MM360 Staff | Jun 2, 2025 | Myeloma News
Source: Pharmacy Times articles Experts discuss BiTE therapy in treating lung cancers, focusing on innovative agents like tarlatamab and amivantimab, and their toxicity management. Read More
by MM360 Staff | Jun 1, 2025 | Myeloma News
Source: Pharmacy Times articles Post Content Read More
by MM360 Staff | Jun 1, 2025 | Uncategorized
Source: ASCO Daily News Dr. John Sweetenham shares highlights from Day 3 of the 2025 ASCO Annual Meeting, including new research for the treatment of advanced renal cell carcinoma and 2 studies on novel approaches in non-small cell lung cancer. Transcript Dr. John...
